Escitalopram in painful polyneuropathy: A randomized, placebo-controlled, cross-over trial

Pain

Volumn 139, Issue 2, 2008, Pages 275-283

  Otto, Marit ^a   Bach, Flemming W ^b   Jensen, Troels S ^c   Brøsen, Kim ^d   Sindrup, Søren H ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b AALBORG UNIVERSITY HOSPITAL   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Escitalopram; Neuropathic pain; Polyneuropathy; Selective serotonin reuptake inhibitors

Indexed keywords

ESCITALOPRAM; PARACETAMOL; PLACEBO; SEROTONIN UPTAKE INHIBITOR;

ABDOMINAL DISCOMFORT; ADULT; AGED; ANALGESIA; ANOREXIA; ANXIETY; ARTICLE; BLURRED VISION; BURNING PAIN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEEP ACHING PAIN; DEPRESSION; DIARRHEA; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FATIGUE; FEMALE; FEVER; HEADACHE; HUMAN; IMPOTENCE; LANCINATING PAIN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION INVENTORY SCALE; MALE; NAUSEA; NERVOUSNESS; NEUROPATHIC PAIN; PAIN ASSESSMENT; PATIENT COMPLIANCE; POLYNEUROPATHY; PRESSURE EVOKED PAIN; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RECOMMENDED DRUG DOSE; SHORT FORM 36; SIDE EFFECT; SINGLE DRUG DOSE; SLEEP DISORDER; SOMNOLENCE; SWEATING; TOUCH EVOKED PAIN; TREATMENT DURATION; URINE RETENTION; VOMITING; XEROSTOMIA;

ADULT; AGED; CITALOPRAM; CROSS-OVER STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEURALGIA; PAIN MEASUREMENT; PLACEBO EFFECT; POLYNEUROPATHIES; SEROTONIN ANTAGONISTS; TREATMENT OUTCOME;

EID: 53049101174     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2008.04.012     Document Type: Article

References (35)

1. Attal N., Cruccu G., Haanpaa M., Hansson P., Jensen T.S., Nurmikko T., et al. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol 13 (2006) 1153-1169
2. Baron R. Mechanisms of disease: neuropathic pain - a clinical perspective. Nat Clin Pract Neurol 2 (2006) 95-106
3. Bech P., Rasmussen N.A., Olsen L.R., Noerholm V., and Abildgaard W. The sensitivity and specificity of the Major Depression Inventory, using the Present State Examination as the index of diagnostic validity. J Affect Disord 66 (2001) 159-164
4. Bjorner J., Damsgaard M., Watt T., Bech P., Rasmussen N., Kristensen T., et al. Dansk manual til SF-36.Et spørgeskema om helbredstatus. København: Lægemiddelindustriforeningen (1997)
5. Cook R.J., and Sackett D.L. The Number Needed to Treat: a clinically useful measure of treatment effect. BMJ 310 (1995) 452-454
6. Finnerup N.B., and Jensen T.S. Mechanisms of disease: mechanism-based classification of neuropathic pain - a critical analysis. Nat Clin Pract Neurol 2 (2006) 107-115
7. Finnerup N.B., Otto M., McQuay H.J., Jensen T.S., and Sindrup S.H. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 118 (2005) 289-305
8. Gilron I., Watson C.P., Cahill C.M., and Moulin D.E. Neuropathic pain: a practical guide for the clinician. CMAJ 175 (2006) 265-275
9. Goldstein D.J., Lu Y., Detke M.J., Lee T.C., and Iyengar S. Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain 116 (2005) 109-118
10. Hyttel J., Bogeso K.P., Perregaard J., and Sanchez C. The pharmacological effect of citalopram residues in the (S)-(+)-enantiomer. J Neural Transm Gen Sect 88 (1992) 157-160
11. Max M.B., Lynch S.A., Muir J., Shoaf S.E., Smoller B., and Dubner R. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 326 (1992) 1250-1256
12. McQuay H.J., Tramer M., Nye B.A., Carroll D., Wiffen P.J., and Moore R.A. A systematic review of antidepressants in neuropathic pain. Pain 68 (1996) 217-227
13. Millan M.J. Descending control of pain. Prog Neurobiol 66 (2002) 355-474
14. Moore N., Verdoux H., and Fantino B. Prospective, multicentre, randomized, double-blind study of the efficacy of escitalopram versus citalopram in outpatient treatment of major depressive disorder. Int Clin Psychopharmacol 20 (2005) 131-137
15. Olsen L.R., Jensen D.V., Noerholm V., Martiny K., and Bech P. The internal and external validity of the Major Depression Inventory in measuring severity of depressive states. Psychol Med 33 (2003) 351-356
16. Otto M., Bach F.W., Jensen T.S., and Sindrup S.H. Valproic acid has no effect on pain in polyneuropathy: a randomized, controlled trial. Neurology 62 (2004) 285-288
17. Owens M.J., Knight D.L., and Nemeroff C.B. Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine. Biol Psychiatry 50 (2001) 345-350
18. Rahman W., Suzuki R., Webber M., Hunt S.P., and Dickenson A.H. Depletion of endogenous spinal 5-HT attenuates the behavioural hypersensitivity to mechanical and cooling stimuli induced by spinal nerve ligation. Pain 123 (2006) 264-274
19. Raskin J., Pritchett Y.L., Wang F., D'Souza D.N., Waninger A.L., Iyengar S., et al. A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. Pain Med 6 (2005) 346-356
20. Rasmussen P.V., Sindrup S.H., Jensen T.S., and Bach F.W. Symptoms and signs in patients with suspected neuropathic pain. Pain 110 (2004) 461-469
21. Rosenstock J., Tuchman M., LaMoreaux L., and Sharma U. Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain 110 (2004) 628-638
22. Rowbotham M., Harden N., Stacey B., Bernstein P., and Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA 280 (1998) 1837-1842
23. Rowbotham M.C., Goli V., Kunz N.R., and Lei D. Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study. Pain 110 (2004) 697-706
24. Saarto T., and Wiffen P.J. Antidepressants for neuropathic pain. Cochrane Database Syst Rev (2005) CD005454
25. Sabatowski R., Galvez R., Cherry D.A., Jacquot F., Vincent E., Maisonobe P., et al. Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial. Pain 109 (2004) 26-35
26. Sanchez C. The pharmacology of citalopram enantiomers: the antagonism by R-citalopram on the effect of S-citalopram. Basic Clin Pharmacol Toxicol 99 (2006) 91-95
27. Scholz J., and Woolf C.J. Can we conquer pain?. Nat Neurosci 5 (2002) 1062-1067
28. Sindrup S.H., Bach F.W., Madsen C., Gram L.F., and Jensen T.S. Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial. Neurology 60 (2003) 1284-1289
29. Sindrup S.H., Bjerre U., Dejgaard A., Brosen K., Aaes-Jorgensen T., and Gram L.F. The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy. Clin Pharmacol Ther 52 (1992) 547-552
30. Sindrup S.H., Gram L.F., Brosen K., Eshoj O., and Mogensen E.F. The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain 42 (1990) 135-144
31. Sindrup S.H., Otto M., Finnerup N.B., and Jensen T.S. Antidepressants in the treatment of neuropathic pain. Basic Clin Pharmacol Toxicol 96 (2005) 399-409
32. Sommer C. Is serotonin hyperalgesic or analgesic?. Curr Pain Headache Rep 10 (2006) 101-106
33. Suzuki R., Rahman W., Rygh L.J., Webber M., Hunt S.P., and Dickenson A.H. Spinal-supraspinal serotonergic circuits regulating neuropathic pain and its treatment with gabapentin. Pain 117 (2005) 292-303
34. Watson C.P., Moulin D., Watt-Watson J., Gordon A., and Eisenhoffer J. Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy. Pain 105 (2003) 71-78
35. Wernicke J.F., Pritchett Y.L., D'Souza D.N., Waninger A., Tran P., Iyengar S., et al. A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain. Neurology 67 (2006) 1411-1420